Graviton Bioscience - Crunchbase Company Profile & Funding

Q: Who invested in Graviton Bioscience?

Graviton Bioscience has 3 investors including Sanofi And Enavate Sciences.

Q: How much funding has Graviton Bioscience raised to date?

Graviton Bioscience has raised obfuscated.

Overview

Graviton Bioscience

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Graviton Bioscience

CB Rank

29750

Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications

Founded

obfuscation

Private

Private Equity

New York, New York, United States

11-50

gravitoncorp.com

Biotechnology

Therapeutics

Funding Rounds

Private Equity

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Samuel D. Waksal: Chief Executive Officer & Founder
Past Role: Equilibre, Founder

Details

Legal Name

Graviton Bioscience

Operating Status

Active

Company Type

For Profit

Founders

Samuel D. Waksal

About the Company

Graviton Bioscience is a clinical-stage drug discovery and development firm focused on creating and developing therapies for the treatment of CNS, autoimmune, fibrotic, and other significant disorders in which ROCK2 plays a critical role in pathology.

Contact Email

info@gravitoncorp.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Selective ROCK2 Inhibitors

A portfolio of inhibitors targeting the ROCK2 kinase to modulate cellular processes involved in fibrotic, autoimmune, and CNS diseases.

Anti-C6 Antibody Therapy

An antibody-based therapy targeting the complement system component C6 to regulate immune activity in neurodegenerative and autoimmune diseases.

Research & Development

Graviton Bioscience is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity
obfuscated obfuscation	Private Equity Round - Graviton Bioscience	2	obfuscated obfuscation	Enavate Sciences, Sanofi	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Sanofi	Yes	Private Equity Round - Graviton Bioscience	Paul Hudson
Sanofi	Yes	Private Equity Round - Graviton Bioscience	Paul Hudson
Sanofi	Yes	Private Equity Round - Graviton Bioscience	Paul Hudson
Sanofi	Yes	Private Equity Round - Graviton Bioscience	Paul Hudson
Sanofi	Yes	Private Equity Round - Graviton Bioscience	Paul Hudson